Prosecution Insights
Last updated: August 17, 2026

Examiner: KONOPKA, CATHERINE ANNE

Tech Center 1600 • Art Units: 1600 1613 1632 1635 1636 1638 1642

This examiner grants 58% of resolved cases

Performance Statistics

58.2%
Allow Rate
-1.8% vs TC avg
251
Total Applications
+64.5%
Interview Lift
1397
Avg Prosecution Days
Based on 194 resolved cases, 2023–2026

Rejection Statute Breakdown

5.2%
§101 Eligibility
14.1%
§102 Novelty
33.1%
§103 Obviousness
30.2%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18553357 Specific Oligonucleotide-Programmed Readthrough of Nonsense Codons Non-Final OA UNIVERSITY OF MASSACHUSETTS
17921027 IMPROVED CAS 12A/NLS MEDIATED THERAPEUTIC GENE EDITING PLATFORMS Non-Final OA UNIVERSITY OF MASSACHUSETTS
18280092 RNAI CONJUGATES AND USES THEREOF Non-Final OA NOVO NORDISK A/S
18267144 METHOD FOR PROGRAMMABLE CONTROL OF RNA TRANSCRIPT LEVELS WITH AUTOREGULATED CRISPR-CAS13D Final Rejection University of Florida Research Foundation, Incorporated
18045873 AAV VARIANTS WITH HOST ANTIBODY ESCAPE CAPABILITIES AND ALTERED TISSUE TARGETING PROPERTIES Final Rejection University of Florida Research Foundation, Incorporated
18048238 DISCOVERY AND ENGINEERING OF INTEGRASES FOR HIGH-EFFICIENCY GENE INTEGRATION Non-Final OA Massachusetts Institute of Technology
18265226 COMPOSITIONS TARGETING WDR37 AND METHODS OF USE THEREOF Non-Final OA THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month